Guidelines on PML risk stratification and diagnosis in patients with MS treated with natalizumab: so far so good?

Affiliations

¹ MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands.
² Department of Neurology, Medical Faculty, Heinrich Heine University Hospital, Düsseldorf, Germany.

Editorial

Mike P Wattjes et al. J Neurol Neurosurg Psychiatry. 2016 Feb.

. 2016 Feb;87(2):115.

doi: 10.1136/jnnp-2015-311386. Epub 2015 Oct 22.

¹ MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands.
² Department of Neurology, Medical Faculty, Heinrich Heine University Hospital, Düsseldorf, Germany.

No abstract available

Keywords: MRI; MULTIPLE SCLEROSIS; NEUROIMMUNOLOGY.

Comment on

Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group.
McGuigan C, Craner M, Guadagno J, Kapoor R, Mazibrada G, Molyneux P, Nicholas R, Palace J, Pearson OR, Rog D, Young CA. McGuigan C, et al. J Neurol Neurosurg Psychiatry. 2016 Feb;87(2):117-25. doi: 10.1136/jnnp-2015-311100. Epub 2015 Oct 22. J Neurol Neurosurg Psychiatry. 2016. PMID: 26492930 Free PMC article. Review.